On November 9, 2017 Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) reported that its management will be presenting at the Jefferies 2017 London Healthcare Conference in London, UK, at the German Equity Forum in Frankfurt, Germany, and at the Annual Berenberg European Conference in Surrey, UK, and will be attending DZ BANK Equity Conference in Frankfurt, Germany, and dbAccess Pharmaceutical and Healthcare Corporate Day in London, UK (Press release, Evotec, NOV 9, 2017, View Source [SID1234521864]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies 2017 London Healthcare Conference, London, UK
Date: Thursday, 16 November 2017, 11.20 am GMT (12.20 pm CET, 06.20 am EST)
Webcast: Click here for the webcast
Venue: London, UK
Attendee: Dr Werner Lanthaler, Chief Executive Officer of Evotec AG

DZ BANK Equity Conference, Frankfurt, Germany
Date: Wednesday, 22 November 2017
Venue: Frankfurt, Germany
Attendee: Dr Werner Lanthaler, Chief Executive Officer of Evotec AG

German Equity Forum, Frankfurt, Germany
Date: Monday, 27 November 2017, 11.30 am CET (10.30 am GMT, 05.30 am EST)
Venue: Frankfurt, Germany
Attendee: Dr Werner Lanthaler, Chief Executive Officer of Evotec AG

dbAccess Pharmaceutical and Healthcare Corporate Day, London, UK
Date: Thursday, 30 November 2017
Venue: London, UK
Attendee: Enno Spillner, Chief Financial Officer of Evotec AG

Annual Berenberg European Conference, Surrey, UK
Date: Wednesday, 06 December 2017, 09.45 am GMT (10.45 am CET, 04.45 am EST)
Venue: Surrey, UK
Attendee: Dr Werner Lanthaler, Chief Executive Officer of Evotec AG